Precursor B-cell lymphoblastic leukemia | Precursor T-Cell Lymphoblastic Leukemia
Item
diagnosed with acute b-precursor or t-cell acute lymphoblastic leukemia (all)
boolean
C1292769 (UMLS CUI [1])
C1961099 (UMLS CUI [2])
criteria Risk Fulfill
Item
meets 1 of the following risk criteria:
boolean
C0243161 (UMLS CUI [1,1])
C0035647 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
Disease Low Risk
Item
low-risk disease, defined by any of the following:
boolean
C0012634 (UMLS CUI [1,1])
C3538919 (UMLS CUI [1,2])
White Blood Cell Count procedure
Item
wbc < 25/nl
boolean
C0023508 (UMLS CUI [1])
Precursor B-cell lymphoblastic leukemia
Item
b-precursor all
boolean
C1292769 (UMLS CUI [1])
Pro-B ALL Exclude
Item
excluding pro-b all
boolean
C1292769 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
Disease High risk
Item
high-risk disease, defined by any of the following:
boolean
C0012634 (UMLS CUI [1,1])
C0332167 (UMLS CUI [1,2])
White Blood Cell Count procedure
Item
wbc ≥ 25/nl
boolean
C0023508 (UMLS CUI [1])
T-Cell ALL | Pro-B ALL
Item
t-cell all or pro-b all
boolean
C1961099 (UMLS CUI [1])
C1292769 (UMLS CUI [2])
t(4;11)(q21;q23)
Item
chromosomal translocation 4/11
boolean
C1515769 (UMLS CUI [1])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Unspecified
Item
not specified
boolean
C0205370 (UMLS CUI [1])
Prior Therapy
Item
prior concurrent therapy:
boolean
C1514463 (UMLS CUI [1])
Steroids | Vincristine | Daunorubicin Hydrochloride
Item
more than 7 days since prior therapy with steroids, vincristine, or daunorubicin hydrochloride
boolean
C0038317 (UMLS CUI [1])
C0042679 (UMLS CUI [2])
C0282123 (UMLS CUI [3])
Cytotoxic Chemotherapy
Item
more than 7 days since prior cytotoxic therapy
boolean
C0677881 (UMLS CUI [1])